United Therapeutics Corp (NAS:UTHR)
$ 360.87 -2.78 (-0.76%) Market Cap: 16.11 Bil Enterprise Value: 13.18 Bil PE Ratio: 15.85 PB Ratio: 2.64 GF Score: 86/100

United Therapeutics Corp at Cowen Health Care Conference Transcript

Mar 07, 2023 / 02:10PM GMT
Release Date Price: $236.77 (-4.54%)
Joseph John;Charles Thome
TD Cowen, Research Division - MD & Senior Research Analyst

Thank you for joining us on our second day of the 43rd Annual Healthcare Conference. I'm Joe Thome, one of the senior biotech analysts here on the team at TD Cowen. And it is my pleasure to have with us today the team from United Therapeutics. We have President and CEO, Mike Benkowitz; and CFO and Treasurer, James Edgemond. And then I'm going to pass it quickly to Dewey for some statements.

Dewey Steadman
United Therapeutics Corporation - Head of IR

Yes. Thanks, Joe. Today, Michael and James will likely make forward-looking statements, so we encourage you to read our SEC filings, specially Forms 10-K and 10-Q for the latest risks and uncertainties related to those forward-looking statements. Thanks.

Questions & Answers

Joseph John;Charles Thome
TD Cowen, Research Division - MD & Senior Research Analyst

Great. Excellent. Well, congratulations on all the progress over the past

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot